Skip to main content
. 2019 Jan 17;3(3):392–405. doi: 10.1002/hep4.1303

Figure 4.

Figure 4

Liver cirrhosis stage‐dependent excess of IL‐22BP. (A) IL‐22BP serum concentrations are shown according to the indicated stage of liver cirrhosis. (B) The ratio of serum concentrations of IL‐22BP divided through serum concentrations of IL‐22 (shown in Fig. 1) were calculated and compared among patients with the indicated stages of liver cirrhosis. Significantly lower ratios of IL‐22BP/IL‐22 are observed in patients with decompensated liver cirrhosis and ACLF compared with patients with compensated liver cirrhosis or healthy controls. (C) IL‐22BP concentrations were quantified at baseline and compared between patients who died or who survived until day 28 of follow‐up. (D) The ratio of serum concentrations of IL‐22BP divided through serum concentrations of IL‐22 were calculated and compared between patients who died or who survived until day 28 of follow‐up. (E) The ratio of IL‐22BP to IL‐22 serum concentration is associated with liver synthesis capacity. The ratio of serum concentrations of IL‐22BP divided through serum concentrations of IL‐22 were calculated in all patients with liver cirrhosis and correlated with INR (left panel) and with serum albumin concentration (right panel). Abbreviations: comp., compensated; decomp., decompensated; and gr., grade.